Install
Home to the journal Oncology, Cancer Network provides research and opinion on the screening, early detection, diagnosis, treatment, and prevention of cancers.
- 153articles · 30d
- 2+ day agolatest article
- Aug 15, 2026earliest in window
- 93%with images
- 252avg words
- Health 153
- Medical 152
- Health & Wellness 148
- Business & Industrial 3
- Finance & Business 1
- Jobs & Education 1
- STEM 1
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
When the Right Treatment Is Not on the Shelf: Confronting Chemotherapy Shortages
4+ day, 5+ hour ago (401+ words) Although shortages periodically capture national attention when widely used agents such as cisplatin or carboplatin become scarce, the problem extends well beyond any single drug. Neil M. Iyengar, MD, Department of Hematology and Oncology, Winship Cancer Institute of Emory University As…...
Herbert Lepor, MD on Focal Cryotherapy, 1,000 Procedures, and Andre De Shields
5+ day, 4+ hour ago (284+ words) Herbert Lepor, MD, discussed NYU Langone's 1,000th focal cryotherapy procedure, Andre De Shields' case, and why prostate cancer treatment is at a turning point. The Moonlight Shift is available on YouTube and across MJH Life Sciences' oncology platforms. New episodes, released…...
How Radiation Oncologists Can Champion World Radiotherapy Awareness Day
5+ day, 23+ hour ago (336+ words) Sandra Turner, MBBS, PhD, shared ideas for radiation oncology teams to engage locally with World Radiotherapy Awareness Day. Ahead of World Radiotherapy Awareness Day (WRAD) on September 7, radiation oncology departments around the world are finding creative ways to engage colleagues,…...
What Does Personalization of Radiopharmaceutical Therapy Require?
1+ week, 4+ day ago (334+ words) In a roundtable discussion hosted for RadOnc on the Run, Brandon Mancini, MD, MBA, FACRO, spoke with Mallika Marar, MD, MBA, and Neil K. Taunk, MD, MSCTS, about fixed-dosing options for radiopharmaceutical therapy and what truly personalized care might require from…...
Speaking With???One Voice??? for World Radiotherapy Awareness Day
1+ week, 4+ day ago (253+ words) Experts highlight the origins and significance of World Radiotherapy Awareness Day and discuss global access challenges surrounding modern radiation oncology. To engage local oncologic communities, Turner highlighted tactics such as hosting morning tea events at hospitals and educational career nights…...
Statistical Design of the CAPItello-291 Final Survival Analysis
1+ week, 5+ day ago (218+ words) Erica L. Mayer, MD, MPH, of Dana-Farber Cancer Institute, explains the statistical framework behind the final overall survival analysis of CAPItello-291, the phase 3 trial of capivasertib plus fulvestrant in hormone receptor positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer....
Rezatapopt Yields Responses, Supports NDA Plan in Ovarian Cancer
1+ week, 5+ day ago (456+ words) Rezatapopt Yields Responses in TP53 Y220C Ovarian Cancer: © Lars Neumann - stock.adobe.com The enrollment of patients with platinum-resistant/refractory ovarian cancer for the primary analysis in the phase 2 monotherapy portion of the trial has been completed. The developer plans to update…...
Nursing Management of Toxicity, Adherence, and Long-Term Care Across First-Line Regimens in EGFR-Mutated Advanced Non???Small Cell Lung Cancer | Around the Practice
1+ week, 6+ day ago (141+ words) Nursing Management of Toxicity, Adherence, and Long-Term Care Across First-Line Regimens in EGFR-Mutated Advanced Non–Small Cell Lung Cancer CancerNetwork Nursing Management of Toxicity, Adherence, and Long-Term Care Across First-Line Regimens in EGFR-Mutated Advanced Non–Small Cell Lung Cancer EP....
Autogene Cevumeran Trial Terminated in Resected Colorectal Cancer
1+ week, 6+ day ago (531+ words) BioNTech has terminated a phase 2 trial of autogene cevumeran in ctDNA-positive, resected colorectal cancer after a DSMB found an overall survival imbalance. Phase 2 mRNA Vaccine Trial in Colorectal Cancer Terminated: © pengfei - stock.adobe.com BioNTech has decided to terminate the…...
ASCO Issues First Living Guideline for Recurrent Ovarian Cancer Treatment
2+ week, 9+ hour ago (253+ words) “The goal of the guideline is to provide the evidence behind standard-of-care treatments for recurrent ovarian cancer that are comprehensive, literature-based, and accessible,” stated expert panel co-chair Jamie Lesnock, MD, of the University of Pittsburgh Medical Center.2 The panel recommends…...